Cargando…

ApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis

BACKGROUND: Atherosclerosis is a chronic inflammatory disease that evolves from the interaction of activated endothelial cells, macrophages, lymphocytes and modified lipoproteins (LDLs). In the last years many molecules with crucial metabolic functions have been shown to prevent important steps in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Sokrates, Lohmann, Christine, Handschin, Christoph, Stenfeldt, Elin, Borén, Jan, Lüscher, Thomas F., Matter, Christian M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962638/
https://www.ncbi.nlm.nih.gov/pubmed/21042583
http://dx.doi.org/10.1371/journal.pone.0013539
_version_ 1782189198097252352
author Stein, Sokrates
Lohmann, Christine
Handschin, Christoph
Stenfeldt, Elin
Borén, Jan
Lüscher, Thomas F.
Matter, Christian M.
author_facet Stein, Sokrates
Lohmann, Christine
Handschin, Christoph
Stenfeldt, Elin
Borén, Jan
Lüscher, Thomas F.
Matter, Christian M.
author_sort Stein, Sokrates
collection PubMed
description BACKGROUND: Atherosclerosis is a chronic inflammatory disease that evolves from the interaction of activated endothelial cells, macrophages, lymphocytes and modified lipoproteins (LDLs). In the last years many molecules with crucial metabolic functions have been shown to prevent important steps in the progression of atherogenesis, including peroxisome proliferator activated receptors (PPARs) and the class III histone deacetylase (HDAC) SIRT1. The PPARγ coactivator 1 alpha (Ppargc1a or PGC-1α) was identified as an important transcriptional cofactor of PPARγ and is activated by SIRT1. The aim of this study was to analyze total PGC-1α deficiency in an atherosclerotic mouse model. METHODOLOGY/PRINCIPAL FINDINGS: To investigate if total PGC-1α deficiency affects atherosclerosis, we compared ApoE(−/−) PGC-1α(−/−) and ApoE(−/−) PGC-1α(+/+) mice kept on a high cholesterol diet. Despite having more macrophages and a higher ICAM-1 expression in plaques, ApoE(−/−) PGC-1α(−/−) did not display more or larger atherosclerotic plaques than their ApoE(−/−) PGC-1α(+/+) littermates. In line with the previously published phenotype of PGC-1α(−/−) mice, ApoE(−/−) PGC-1α(−/−) mice had marked reduced body, liver and epididymal white adipose tissue (WAT) weight. VLDL/LDL-cholesterol and triglyceride contents were also reduced. Aortic expression of PPARα and PPARγ, two crucial regulators for adipocyte differentitation and glucose and lipid metabolism, as well as the expression of some PPAR target genes was significantly reduced in ApoE(−/−) PGC-1α(−/−) mice. Importantly, the epididymal WAT and aortic expression of IL-18 and IL-18 plasma levels, a pro-atherosclerotic cytokine, was markedly reduced in ApoE(−/−) PGC-1α(−/−) mice. CONCLUSIONS/SIGNIFICANCE: ApoE(−/−) PGC-1α(−/−) mice, similar as PGC-1α(−/−) mice exhibit markedly reduced total body and visceral fat weight. Since inflammation of visceral fat is a crucial trigger of atherogenesis, decreased visceral fat in PGC-1α-deficient mice may explain why these mice do not develop enhanced atherosclerosis.
format Text
id pubmed-2962638
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29626382010-11-01 ApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis Stein, Sokrates Lohmann, Christine Handschin, Christoph Stenfeldt, Elin Borén, Jan Lüscher, Thomas F. Matter, Christian M. PLoS One Research Article BACKGROUND: Atherosclerosis is a chronic inflammatory disease that evolves from the interaction of activated endothelial cells, macrophages, lymphocytes and modified lipoproteins (LDLs). In the last years many molecules with crucial metabolic functions have been shown to prevent important steps in the progression of atherogenesis, including peroxisome proliferator activated receptors (PPARs) and the class III histone deacetylase (HDAC) SIRT1. The PPARγ coactivator 1 alpha (Ppargc1a or PGC-1α) was identified as an important transcriptional cofactor of PPARγ and is activated by SIRT1. The aim of this study was to analyze total PGC-1α deficiency in an atherosclerotic mouse model. METHODOLOGY/PRINCIPAL FINDINGS: To investigate if total PGC-1α deficiency affects atherosclerosis, we compared ApoE(−/−) PGC-1α(−/−) and ApoE(−/−) PGC-1α(+/+) mice kept on a high cholesterol diet. Despite having more macrophages and a higher ICAM-1 expression in plaques, ApoE(−/−) PGC-1α(−/−) did not display more or larger atherosclerotic plaques than their ApoE(−/−) PGC-1α(+/+) littermates. In line with the previously published phenotype of PGC-1α(−/−) mice, ApoE(−/−) PGC-1α(−/−) mice had marked reduced body, liver and epididymal white adipose tissue (WAT) weight. VLDL/LDL-cholesterol and triglyceride contents were also reduced. Aortic expression of PPARα and PPARγ, two crucial regulators for adipocyte differentitation and glucose and lipid metabolism, as well as the expression of some PPAR target genes was significantly reduced in ApoE(−/−) PGC-1α(−/−) mice. Importantly, the epididymal WAT and aortic expression of IL-18 and IL-18 plasma levels, a pro-atherosclerotic cytokine, was markedly reduced in ApoE(−/−) PGC-1α(−/−) mice. CONCLUSIONS/SIGNIFICANCE: ApoE(−/−) PGC-1α(−/−) mice, similar as PGC-1α(−/−) mice exhibit markedly reduced total body and visceral fat weight. Since inflammation of visceral fat is a crucial trigger of atherogenesis, decreased visceral fat in PGC-1α-deficient mice may explain why these mice do not develop enhanced atherosclerosis. Public Library of Science 2010-10-22 /pmc/articles/PMC2962638/ /pubmed/21042583 http://dx.doi.org/10.1371/journal.pone.0013539 Text en Stein et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Stein, Sokrates
Lohmann, Christine
Handschin, Christoph
Stenfeldt, Elin
Borén, Jan
Lüscher, Thomas F.
Matter, Christian M.
ApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis
title ApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis
title_full ApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis
title_fullStr ApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis
title_full_unstemmed ApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis
title_short ApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis
title_sort apoe−/− pgc-1α−/− mice display reduced il-18 levels and do not develop enhanced atherosclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962638/
https://www.ncbi.nlm.nih.gov/pubmed/21042583
http://dx.doi.org/10.1371/journal.pone.0013539
work_keys_str_mv AT steinsokrates apoepgc1amicedisplayreducedil18levelsanddonotdevelopenhancedatherosclerosis
AT lohmannchristine apoepgc1amicedisplayreducedil18levelsanddonotdevelopenhancedatherosclerosis
AT handschinchristoph apoepgc1amicedisplayreducedil18levelsanddonotdevelopenhancedatherosclerosis
AT stenfeldtelin apoepgc1amicedisplayreducedil18levelsanddonotdevelopenhancedatherosclerosis
AT borenjan apoepgc1amicedisplayreducedil18levelsanddonotdevelopenhancedatherosclerosis
AT luscherthomasf apoepgc1amicedisplayreducedil18levelsanddonotdevelopenhancedatherosclerosis
AT matterchristianm apoepgc1amicedisplayreducedil18levelsanddonotdevelopenhancedatherosclerosis